Abstract
Recent progress in the development of noninvasive imaging technologies should allow molecular imaging to play a major role in the field of gene therapy. These tools have recently been validated in gene therapy models for continuous quantitative monitoring of the location(s), magnitude, and time variation of gene delivery and/or expression. This article reviews the use of radionuclide, magnetic resonance, and optical imaging technologies, as they have been used in imaging gene delivery and gene expression for gene therapy applications. The studies published to date lend support that noninvasive imaging tools will help to accelerate preclinical model validation, as well as allow for clinical monitoring of human gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gambhir SS . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683–693.
Massoud TF, Gambhir SS . Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545–580.
Bogdanov A, Weissleder R . In vivo imaging of gene delivery and expression. Trends Biotechnol 2002; 20: S11–S18.
Blasberg R . PET imaging of gene expression. Eur J Cancer 2002; 38: 2137–2146.
Blasberg R . Imaging gene expression and endogenous molecular processes: molecular imaging. J Cereb Blood Flow Metab 2002; 22: 1157–1164.
Wunderbaldinger P, Bogdanov A, Weissleder R . New approaches for imaging in gene therapy. Eur J Radiol 2000; 34: 156–165.
Weissleder R, Mahmood U . Molecular imaging. Radiology 2001; 219: 316–333.
Nichol C, Kim EE . Molecular imaging and gene therapy. J Nucl Med 2001; 42: 1368–1374.
Gambhir SS et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000; 2: 118–138.
Allport JR, Weissleder R . In vivo imaging of gene and cell therapies. Exp Hematol 2001; 29: 1237–1246.
Yang M et al. Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci USA 2000; 97: 12278–12282.
Jakobs S et al. EGFP and DsRed expressing cultures of Escherichia coli imaged by confocal, two-photon and fluorescence lifetime microscopy. FEBS Lett 2000; 479: 131–135.
Contag CH, Ross BD . It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 2002; 16: 378–387.
Bhaumik S, Gambhir SS . Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 2002; 99: 377–382.
Wu JC, Sundaresan G, Iyer M, Gambhir SS . Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 2001; 4: 297–306.
Contag CH, Jenkins D, Contag PR, Negrin RS . Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2: 41–52.
Ntziachristos V, Tung CH, Bremer C, Weissleder R . Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002; 8: 757–760.
Weissleder R . Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2002; 2: 11–18.
Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R . Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Therapy 2000; 7: 1648–1655.
Murugesan S, Sundaresan G, Gambhir S . In vivo imaging of Tc-99m adenovirus and reporter gene expression in living subjects. Mol Imaging 2003; 2: 288.
Sundaresan G, Murugesan S, Gambhir S . MicroPET imaging of I-124 adenovirus biodistribution and optical imaging of reporter gene expression in living subjects. Mol Imaging 2003; 2: 302.
Bogdanov Jr A, Tung CH, Bredow S, Weissleder R . DNA binding chelates for nonviral gene delivery imaging. Gene Therapy 2001; 8: 515–522.
Harrington KJ et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001; 7: 243–254.
Harrison Jr LH et al. Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma. Ann Thorac Surg 2000; 70: 407–411.
Adonai N et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 2002; 99: 3030–3035.
Le LQ et al. Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene. Cancer Cell 2002; 1: 381–391.
Ponomarev V et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 2001; 3: 480–488.
Dubey P et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA 2003; 100: 1232–1237.
Koehne G et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 2003; 21: 405–413.
Modo M et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002; 17: 803–811.
Lewin M et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410–414.
Weninger W, Manjunath N, Von Andrian UH . Migration and differentiation of CD8+ T cells. Immunol Rev 2002; 186: 221–233.
Hardy J et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 2001; 29: 1353–1360.
Ray P et al. Monitoring gene therapy with reporter gene imaging. Semin Nucl Med 2001; 31: 312–320.
Min JJ, Iyer M, Gambhir SS . Comparison of FHBG and FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection versus stable transfection. Eur J Nucl Med Mol Imaging 2003; 30: 1547–1560.
Tjuvajev JG et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002; 43: 1072–1083.
Herschman HR . Micro-PET imaging and small animal models of disease. Curr Opin Immunol 2003; 15: 378–384.
Zinn KR, Chaudhuri TR . The type 2 human somatostatin receptor as a platform for reporter gene imaging. Eur J Nucl Med Mol Imaging 2002; 29: 388–399.
Chung JK . Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 2002; 43: 1188–1200.
Spitzweg C, Morris JC . The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol (Oxf) 2002; 57: 559–574.
Haberkorn U, Altmann A, Eisenhut M . Functional genomics and proteomics – the role of nuclear medicine. Eur J Nucl Med Mol Imaging 2002; 29: 115–132.
Liang Q et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Therapy 2001; 8: 1490–1498.
Gambhir SS et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000; 97: 2785–2790.
Jacobs A et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001; 358: 727–729.
Haberkorn U et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Therapy 2003; 10: 774–780.
Cho JY et al. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Therapy 2002; 9: 1139–1145.
Min JJ et al. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol 2002; 29: 537–545.
Groot-Wassink T et al. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002; 13: 1723–1735.
Ray P, Wu AM, Gambhir SS . Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res 2003; 63: 1160–1165.
Richard JC et al. Imaging pulmonary gene expression with positron emission tomography (PET). Am J Respir Crit Care Med 2002; 167: 1257–1263.
Ray P, Min JJ, Gambhir S . Multimodality imaging of reporter gene expression in single cells and living mice using a novel triple fusion vector. J Nucl Med 2003; 44: 30.
Liang Q et al. Noninvasive, repetitive, quantitative measurement of gene expression from bicistronic message by positron emission tomography, following gene transfer with adenovirus. Mol Ther 2002; 6.
Yu Y et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 2000; 6: 933–937.
Wang YL et al. New approaches for linking PET & therapeutic reporter gene expression for imaging gene therapy with increased sensitivity. J Nucl Med 2001; 42: 75.
Zinn KR et al. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology 2002; 223: 417–425.
Hemminki A et al. In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. J Natl Cancer Inst 2002; 94: 741–749.
Sun X et al. Quantitative imaging of gene induction in living animals. Gene Therapy 2001; 8: 1572–1579.
Yaghoubi SS et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Therapy 2001; 8: 1072–1080.
Doubrovin M et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci USA 2001; 98: 9300–9305.
Iyer M et al. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci USA 2001; 98: 14595–14600.
Iyer M et al. Two step transcriptional amplification (TSTA) for enhancing HSV1-sr39tk reporter gene expression using a new single vector feedback strategy. J Nucl Med 2002; 43: 68.
Qiao J et al. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Therapy 2002; 9: 168–175.
Zhang L et al. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther 2002; 5: 223–232.
Zhang L et al. Interrogating androgen receptor function in recurrent prostate cancer. Cancer Res 2003; 63: 4552–4560.
Sato M et al. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther 2003; 8: 726–737.
Bennett JJ et al. Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. Nat Med 2001; 7: 859–863.
Jacobs A et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res 2001; 61: 2983–2995.
Weissleder R et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6: 351–355.
Moore A et al. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001; 221: 244–250.
Ichikawa T et al. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 2002; 4: 523–530.
Louie AH et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18: 321–325.
Stegman LD et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Therapy 2000; 7: 1005–1010.
Pfeifer A et al. Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther 2001; 3: 319–322.
Tsui LV et al. Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat Biotechnol 2002; 20: 53–57.
Adams JY et al. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 2002; 8: 891–897.
Iyer M, Berenji M, Templeton NS, Gambhir SS . Noninvasive imaging of cationic lipid-mediated delivery of optical and PET reporter genes in living mice. Mol Ther 2002; 6: 555–562.
Hildebrandt IJ, Iyer M, Wagner E, Gambhir SS . Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Therapy 2003; 10: 758–764.
Hajjar RJ, del Monte F, Matsui T, Rosenzweig A . Prospects for gene therapy for heart failure. Circ Res 2000; 86: 616–621.
Bengel FM et al. Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene – the cellular basis for cardiac gene imaging. Circulation 2000; 102: 948–950.
Wu JC et al. Optical imaging of cardiac reporter gene expression in living rats. Circulation 2002; 105: 1631–1634.
Wu JC et al. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 2002; 106: 180–183.
Inubushi MWJ et al. PET reporter gene expression imaging in rat myocardium. Circulation 2002; 107: 326–332.
Chen IY et al. MicroPET imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery. J Nucl Med 2003; 44: 1.
Wu JC et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 2003; 108: 1302–1305.
Bankiewicz KS et al. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol 2000; 164: 2–14.
Hoehn M et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 99: 16267–16272.
Bohnen NI et al. Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med 2000; 25: 447–450.
Colombo FR et al. Biodistribution studies of 99mTc-labeled myoblasts in a murine model of muscular dystrophy. Nucl Med Biol 2001; 28: 935–940.
Walter G, Barton ER, Sweeney HL . Noninvasive measurement of gene expression in skeletal muscle. Proc Natl Acad Sci USA 2000; 97: 5151–5155.
Auricchio A, Zhou R, Wilson JM, Glickson JD . In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc Natl Acad Sci USA 2001; 98: 5205–5210.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Min, J., Gambhir, S. Gene Therapy Progress and Prospects: Noninvasive imaging of gene therapy in living subjects. Gene Ther 11, 115–125 (2004). https://doi.org/10.1038/sj.gt.3302191
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302191
Keywords
This article is cited by
-
Use of Molecular Imaging in Clinical Drug Development: a Systematic Review
Nuclear Medicine and Molecular Imaging (2019)
-
Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer Vectors
Scientific Reports (2017)
-
From Gene Engineering to Gene Modulation and Manipulation: Can We Prevent or Detect Gene Doping in Sports?
Sports Medicine (2013)
-
Utilization of Neural Stem Cell-Derived Models to Study Anesthesia-Related Toxicity and Preventative Approaches
Molecular Neurobiology (2013)
-
Suicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporter
Gene Therapy (2011)